QV Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57M Sell
25,880
-850
-3% -$198K 0.51% 50
2026
Q1
$6.53M Sell
26,730
-57,680
-68% -$13.4M 0.53% 46
2025
Q4
$17.5M Sell
84,410
-55,980
-40% -$11.1M 1.43% 25
2025
Q3
$26M Buy
140,390
+39,150
+39% +$6.71M 2.25% 16
2025
Q2
$15.5M Buy
101,240
+580
+0.6% +$89.2K 1.52% 25
2025
Q1
$16.7M Sell
100,660
-4,280
-4% -$670K 1.69% 17
2024
Q4
$15.2M Buy
104,940
+7,570
+8% +$1.17M 1.56% 24
2024
Q3
$15.8M Buy
97,370
+260
+0.3% +$41.4K 1.39% 29
2024
Q2
$14.2M Sell
97,110
-1,770
-2% -$263K 1.33% 26
2024
Q1
$15.6M Sell
98,880
-870
-0.9% -$138K 1.36% 29
2023
Q4
$15.6M Buy
99,750
+28,960
+41% +$4.44M 1.41% 24
2023
Q3
$11M Sell
70,790
-750
-1% -$124K 1.14% 31
2023
Q2
$11.8M Sell
71,540
-2,330
-3% -$376K 1.07% 32
2023
Q1
$11.4M Sell
73,870
-15,310
-17% -$2.47M 1.07% 31
2022
Q4
$15.8M Sell
89,180
-37,220
-29% -$6.43M 1.51% 25
2022
Q3
$20.6M Sell
126,400
-7,640
-6% -$1.29M 1.99% 18
2022
Q2
$23.8M Sell
134,040
-410
-0.3% -$73K 2.17% 20
2022
Q1
$23.8M Sell
134,450
-3,430
-2% -$584K 1.69% 23
2021
Q4
$23.6M Buy
137,880
+31,370
+29% +$5.14M 1.64% 23
2021
Q3
$17.2M Sell
106,510
-21,120
-17% -$3.6M 1.3% 25
2021
Q2
$21M Sell
127,630
-3,860
-3% -$639K 1.28% 22
2021
Q1
$21.6M Sell
131,490
-9,040
-6% -$1.46M 1.33% 24
2020
Q4
$22.1M Sell
140,530
-21,340
-13% -$3.15M 1.45% 19
2020
Q3
$24.1M Sell
161,870
-10,610
-6% -$1.57M 1.64% 21
2020
Q2
$24.3M Sell
172,480
-24,120
-12% -$3.51M 1.62% 21
2020
Q1
$25.8M Buy
196,600
+47,760
+32% +$6.78M 2.21% 12
2019
Q4
$21.7M Sell
148,840
-12,600
-8% -$1.71M 0.91% 29
2019
Q3
$20.9M Sell
161,440
-7,010
-4% -$924K 0.63% 30
2019
Q2
$23.5M Buy
168,450
+166,850
+10,428% +$23.1M 0.75% 29
2019
Q1
$223K Sell
1,600
-60
-4% -$8.04K 0.01% 41
2018
Q4
$214K Buy
1,660
+140
+9% +$19.5K 0.01% 39
2018
Q3
$210K Hold
1,520
0.01% 43
2018
Q2
$184K Sell
1,520
-210
-12% -$26.2K ﹤0.01% 46
2018
Q1
$221K Buy
1,730
+90
+5% +$12.2K ﹤0.01% 48
2017
Q4
$229K Buy
1,640
+130
+9% +$18.1K ﹤0.01% 48
2017
Q3
$196K Sell
1,510
-35,055
-96% -$4.65M ﹤0.01% 47
2017
Q2
$4.84M Buy
36,565
+2,310
+7% +$295K 0.11% 49
2017
Q1
$4.27M Buy
34,255
+2,908
+9% +$347K 0.44% 31
2016
Q4
$3.61M Buy
31,347
+6,907
+28% +$798K 0.4% 30
2016
Q3
$2.89M Buy
24,440
+15
+0.1% +$1.82K 0.35% 31
2016
Q2
$2.96M Hold
24,425
0.38% 29
2016
Q1
$2.64M Buy
24,425
+5,250
+27% +$544K 0.35% 29
2015
Q4
$1.97M Buy
+19,175
New +$1.93M 0.26% 30

Other funds holding JNJ

QV Investors's JNJ Position: Q2 2026 in Review

QV Investors reduced its Johnson & Johnson (JNJ) stake by 3.2% in Q2 2026, selling an estimated $198K and leaving 25,880 shares worth $6.57M. The position accounts for 0.51% of the portfolio, ranked #50.

QV Investors first reported a position in JNJ in Q4 2015 and has held it in 43 quarters since. The position peaked at $26M in Q3 2025. 1,670 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • QV Investors held 25,880 shares of Johnson & Johnson worth $6.57M as of Q2 2026.
  • QV Investors sold 850 Johnson & Johnson shares in Q2 2026, an estimated $198K.
  • Johnson & Johnson made up 0.51% of QV Investors's portfolio in Q2 2026, its #50 holding.
  • QV Investors first reported a position in Johnson & Johnson in Q4 2015 and has held it in 43 quarters since.
  • QV Investors's Johnson & Johnson position peaked at $26M in Q3 2025.
  • 1,670 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on QV Investors's 13F filing for Q2 2026, filed 21 Jul 2026.